EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer

Lee J Pribyl iD, Jennifer E Kay iD, Joshua J Corrigan iD, Lindsay B Volk iD, Monét Norales, Norah A Owiti, Evan A Kowal, Ishwar N Kohale, Ilana S Nazari, Matilda R Swanson, Aimee C Moise, Duanduan Ma und 12 weitere

NAR Cancer · 08.04.2026 · 8 (2)

DOI: 10.1093/narcan/zcag014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 23.06.2026. Verfasst von Lee J Pribyl und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States. Hauptthemen laut MEDLINE: DNA Methylation, Liver Neoplasms, DNA Damage, Interferons. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, NIEHS Superfund Research Program Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-Nitrosodimethylamine (NDMA), a probable human carcinogen, induces toxic and mutagenic DNA O6-methylguanine (O6MeG) adducts that are repaired by O6-methylguanine-DNA methyltransferase (MGMT). To elucidate how early-life environmental mutagenic exposures promote latent liver tumorigenesis, we performed longitudinal studies in wild-type and MGMT-deficient (Mgmt−/−) mice. Neonatal mice received NDMA intraperitoneally on postnatal days 8 and 15 and were followed for up to 10 months post-exposure. Phenomics, transcriptomics, phosphoproteomics, spatial transcriptomics, and histopathology revealed that NDMA exposure in Mgmt−/− mice produced a nine-fold increase in liver tumors, including hepatocellular carcinomas and adenomas. Early molecular profiling revealed elevated O6MeG adducts, sustained γH2AX activation, and increased micronucleus formation in Mgmt−/− livers. Transcriptomics showed persistent interferon response and immune cell infiltration, particularly in Mgmt−/− mice, up to 10 months post-exposure. Clonal expansion, quantified by RaDR-GFP expression, was significantly higher in NDMA-exposed Mgmt−/− mice. Spatial transcriptomics of clonally expanded cells demonstrated activation of oncogenic and inflammatory pathways. These findings demonstrate that acute early-life NDMA exposure drives persistent DNA damage signaling, chronic interferon activation, and clonal expansion that together promote MGMT-dependent hepatocarcinogenesis. Collectively, these processes link early environmental mutagen exposure to long-term premalignant evolution and tumor emergence, and define mechanistic biomarkers and potential interception targets for NDMA-induced liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationLiver NeoplasmsDNA DamageInterferonsCarcinoma, HepatocellularAnimalsSignal TransductionMiceMice, KnockoutDimethylnitrosamineTumor Suppressor ProteinsDNA Modification MethylasesDNA Repair Enzymes

Substanzen

InterferonsDimethylnitrosamineTumor Suppressor ProteinsMGMT protein, mouseDNA Modification MethylasesDNA Repair Enzymes

Autor:innen und Institutionen

  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
  • Silent Spring Institute, Newton, MA 02460, United States.
  • David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
  • BioMicro Center, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
  • Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
  • TissueVision, Inc., Newton, MA 02458, United States.

ORCID-Profile: Lee J Pribyl, Jennifer E Kay, Joshua J Corrigan, Lindsay B Volk, John M Essigmann, Forest M White, Bevin P Engelward

Förderung

  • NCI NIH HHS
  • NIEHS NIH HHS
  • NIEHS Superfund Research Program Grant
  • NIEHS
  • NIH
  • Anonymous Fund for Climate Action

Zitieren

APA

Pribyl, L. J., Kay, J. E., Corrigan, J. J., Volk, L. B., Norales, M., Owiti, N. A., Kowal, E. A., Kohale, I. N., Nazari, I. S., Swanson, M. R., Moise, A. C., Ma, D., Levine, S. S., Michelsen, E. M., Croy, R. G., Ragan, T., Torous, D. K., Avlasevich, S. L., Dertinger, S. D., …, & Engelward, B. P. (2026). Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer. NAR Cancer, 8(2). https://doi.org/10.1093/narcan/zcag014

Vancouver

Pribyl LJ, Kay JE, Corrigan JJ, Volk LB, Norales M, Owiti NA, et al. Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer. NAR Cancer. 2026;8(2). doi:10.1093/narcan/zcag014

BibTeX
@article{Pribyl2026,
  author = {Pribyl, Lee J and Kay, Jennifer E and Corrigan, Joshua J and Volk, Lindsay B and Norales, Monét and Owiti, Norah A and Kowal, Evan A and Kohale, Ishwar N and Nazari, Ilana S and Swanson, Matilda R and Moise, Aimee C and Ma, Duanduan and Levine, Stuart S and Michelsen, Emily M and Croy, Robert G and Ragan, Timothy and Torous, Dorothea K and Avlasevich, Svetlana L and Dertinger, Stephen D and Carrasco, Sebastian E and Samson, Leona D and Essigmann, John M and White, Forest M and Engelward, Bevin P},
  title = {Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer},
  journal = {NAR Cancer},
  year = {2026},
  volume = {8},
  number = {2},
  doi = {10.1093/narcan/zcag014}
}
Kostenlos starten →